United States Antimony Corp
7 nominees · 3 ballot items.
Elect seven directors; approve an amendment to the Certificate of Formation to increase authorized common shares (increase total authorized shares to 550,000,000, including 500,000,000 common); and ratify Assure CPA, LLC as independent auditor for 2026.
Follow how the vote landed and what changed on United States Antimony Corp’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
On the ballot3
- 1
Election of Directors
ManagementBoard: FORElect each of the seven named director nominees to hold office for a one-year term.
- 2
Approve Amendment to the Certificate of Formation to Increase Authorized Shares
ManagementBoard: FORApprove an amendment to the Certificate of Formation to increase total authorized shares from 300,000,000 (250,000,000 common and 50,000,000 preferred) to 550,000,000 (500,000,000 common and 50,000,000 preferred).
More detail
This proposal asks shareholders to approve an amendment to the Company’s Certificate of Formation to increase total authorized shares of capital stock from 300,000,000 (250,000,000 common and 50,000,000 preferred) to 550,000,000 (500,000,000 common and 50,000,000 preferred). Management and the Board present the change as a general corporate flexibility measure to permit future equity financings, acquisitions, grants under equity compensation plans, issuance of equity-linked securities, and other uses of equity without the delay or burden of convening a special shareholder vote for each issuance; the Board explicitly states it has no present plan to issue the new shares other than routine reserve for compensation and outstanding warrants. The Board also discloses that if approved it reserves the discretion to abandon the increase before it is filed and effective, and it will only effect the increase by filing a Certificate of Amendment with the Texas Secretary of State. The company explains the potential impacts: existing shareholders would experience dilution if additional shares are issued, the market could view the authorization as dilutive pressure on the stock price, and under some circumstances the additional authorized shares could be used in ways that have anti-takeover effects. The Board frames these effects as incidental and not the motivation for the proposal, emphasizing the business need for flexibility to execute financings or strategic transactions in a timely manner. The proposal includes specific factual context about current authorized and reserved shares, outstanding warrants and the share shortfall risk for future transactions. The Board recommends a FOR vote, arguing that lack of additional authorized shares could limit the Company’s ability to raise capital or complete transactions in a timely way, which could materially harm growth prospects; the Board also reiterates that any issuance would be evaluated on terms it believes are in the best interests of existing shareholders.
- 3
Ratification of Appointment of Independent Registered Public Accounting Firm
ManagementBoard: FORRatify the Audit Committee’s selection of Assure CPA, LLC as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.
Nominees on the ballot7
Top institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | VAN ECK ASSOCIATES CORP | 7.0% | 10,369,695 | $91M |
| 2 | STATE STREET CORP | 5.4% | 8,047,077 | $70M |
| 3 | DRIEHAUS CAPITAL MANAGEMENT LLC | 3.6% | 5,345,710 | $47M |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 3.5% | 5,200,486 | $45M |
| 5 | BlackRock, Inc. | 3.2% | 4,802,076 | $42M |
| 6 | BlackRock, Inc. | 2.5% | 3,717,097 | $32M |
| 7 | Hood River Capital Management LLC | 1.9% | 2,759,376 | $24M |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 1.6% | 2,301,006 | $20M |
| 9 | AMERIPRISE FINANCIAL INC | 1.4% | 2,067,340 | $18M |
| 10 | UBS Group AG | 1.2% | 1,839,172 | $16M |
Other Basic Materials sector meetings6
Upcoming shareholder meetings at United States Antimony Corp’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Frequently asked questions
- When is the United States Antimony Corp 2026 annual meeting?
- United States Antimony Corp (UAMY) holds its 2026 annual shareholder meeting on Friday, June 12, 2026.
- What is the record date for the United States Antimony Corp 2026 meeting?
- The record date for the United States Antimony Corp 2026 meeting is Wednesday, April 15, 2026. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for United States Antimony Corp's 2026 meeting?
- The board is presenting 7 director nominees at the United States Antimony Corp 2026 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the United States Antimony Corp 2026 meeting?
- Shareholders will vote on 3 proposals at the United States Antimony Corp 2026 meeting, each tagged with who proposed it and the board's recommendation.
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.